Skip to main content
logo
Hologic, Inc. (HOLX)
Apr 7, 2026 - HOLX was delisted (reason: acquired by Blackstone and TPG)
76.01
0.00 (0.00%)
Inactive · Last trade price on Apr 6, 2026

Revenue Breakdown

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
Diagnostics Revenue
1.82B1.83B1.78B
Breast Health Revenue
1.49B1.48B1.52B
GYN Surgical Revenue
694.20M679.80M641.30M
Skeletal Health Revenue
120.20M109.40M84.10M
Revenue (Other)
100.00K--
Revenue (Total)
4.13B4.10B4.03B

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
United States Revenue
3.06B3.05B3.02B
Europe Revenue
603.70M591.00M532.70M
Asia-Pacific Revenue
240.30M243.30M259.60M
Rest of World Revenue
219.10M218.30M213.90M
Revenue (Total)
4.13B4.10B4.03B

Revenue Breakdown 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
Disposables Revenue
2.60B2.62B2.49B
Capital Equipment, Components and Software Revenue
671.40M638.40M764.90M
Service Revenue
837.90M825.50M758.20M
Other Sources Revenue
19.00M18.90M17.00M
Revenue (Total)
4.13B4.10B4.03B

EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
Diagnostics Income from Operations
-599.90M509.50M
Breast Health Income from Operations
-436.80M476.70M
GYN Surgical Income from Operations
-204.60M224.50M
Skeletal Health Income from Operations
--3.70M-500.00K
Operating Income (Total)
721.50M714.30M882.60M

EBIT 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
Diagnostics Operating Income (Pre-Q4 2025 Reporting)
--303.10M
Breast Health Operating Income (Pre-Q4 2025 Reporting)
--394.50M
GYN Surgical Operating Income (Pre-Q4 2025 Reporting)
--185.50M
Skeletal Health Operating Income (Pre-Q4 2025 Reporting)
---500.00K
Operating Income (Total)
721.50M714.30M882.60M

Capital Expenditures

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16 Sep '15 Sep '14 Sep '13
Diagnostics Capital Expenditures
92.60M86.70M80.20M
Breast Health Capital Expenditures
16.60M19.90M30.90M
GYN Surgical Capital Expenditures
26.30M25.10M16.60M
Skeletal Health Capital Expenditures
-400.00K1.40M
Corporate Capital Expenditures
4.60M4.90M1.10M